Item 5.07 Submission of Matters to a Vote of Security Holders.

AbbVie Inc. ("AbbVie") held its Annual Meeting of Stockholders on May 6, 2022. The following is a summary of the matters voted on at that meeting.

(1) The stockholders elected AbbVie's Class I Directors with terms expiring in


    2025, as follows:




Name                     For             Against      Broker Non-Votes
William H. L. Burnside   1,192,356,325   39,395,112   259,540,346
Thomas C. Freyman        1,197,976,130   33,775,307   259,540,346
Brett J. Hart            1,192,330,735   39,420,702   259,540,346
Edward J. Rapp           1,133,656,046   98,095,391   259,540,346

(2) The stockholders ratified the appointment of Ernst & Young LLP as AbbVie's


    independent registered public accounting firm for 2022, as follows:




For             Against     Abstain
1,478,250,755   9,770,581   3,270,447

(3) The stockholders approved, on an advisory basis, the compensation of AbbVie's


    named executive officers listed in the proxy statement for the 2022 annual
    meeting, as follows:




For             Against       Abstain     Broker Non-Votes
1,096,289,157   128,833,558   6,628,722   259,540,346

(4) The stockholders did not approve the management proposal regarding amendment


    of the certificate of incorporation to eliminate supermajority voting, as
    follows:




For             Against     Abstain     Broker Non-Votes
1,218,279,066   8,897,735   4,574,636   259,540,346

(5) The stockholders did not approve a stockholder proposal to adopt a policy to


    require an independent chair, as follows:




For           Against       Abstain     Broker Non-Votes
371,759,169   854,161,715   5,830,553   259,540,346

(6) The stockholders approved a stockholder proposal to seek shareholder approval


    of certain termination pay arrangements, as follows:




For           Against       Abstain     Broker Non-Votes
617,084,685   608,049,472   6,617,280   259,540,346

(7) The stockholders did not approve a stockholder proposal to issue a report on


    board oversight of competition practices, as follows:




For           Against       Abstain      Broker Non-Votes
404,279,676   810,098,505   17,373,256   259,540,346

(8) The stockholders did not approve a stockholder proposal to issue an annual


    report on political spending, as follows:




For           Against       Abstain     Broker Non-Votes
484,276,406   740,658,343   6,816,668   259,540,346

© Edgar Online, source Glimpses